% Expired Patents = 50.0

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 46

Loading Chart...

6 inventors (with patents filed for the assignee):

Xiao-Yi Xiao (6 out of 35 patents)

Dinesh Vinoobhai Patel (4 out of 60 patents)

John S Ward (4 out of 40 patents)

4. Mark R Bray (2 out of 12 patents)

5. Sampath Kumar Anandan (2 out of 12 patents)

6. Anthony Treston (2 out of 14 patents)

7. Gregory E Agoston (2 out of 9 patents)

8. Dinish V Patel (2 out of 2 patents)

6 patents: Sort by Forward Citations

1. 8153630 - Kinase inhibitors (2012-04-10),

2. 8114870 - Method of treating disease states using substituted pyrazole compounds (2012-02-14),

3. 7772245 - Inhibitors of histone deacetylase (2010-08-10),

4. 7563787 - Substituted pyrazole compounds (2009-07-21),

5. 7371875 - Cytotoxic agents and methods of use (2008-05-13),

6. 7345043 - Inhibitors of histone deacetylase (2008-03-18),

Company Overview

Miikana Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for treating neurodegenerative diseases. Our cutting-edge research and technology platform aim to revolutionize the treatment landscape for conditions like Alzheimer's and Parkinson's. With a team of expert scientists and industry leaders, we are committed to advancing innovative solutions to improve patient outcomes and quality of life.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#93 in Rockville, MD

#635 in Maryland

#45,007 in US

Rockville, MD, United States of America

Miikana Therapeutics, Inc.

Forward Citations = 46

6 inventors:

Xiao-Yi Xiao (6 out of 35 patents)

Dinesh Vinoobhai Patel (4 out of 60 patents)

John S Ward (4 out of 40 patents)

4. Mark R Bray (2 out of 12 patents)

5. Sampath Kumar Anandan (2 out of 12 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Miikana Therapeutics, Inc.. Retrieved from https://idiyas.com/company/miikana-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]